Director, Data Analytics

Zydus Therapeutics Inc (ZTI) is a clinical stage, specialty-focused bio-pharmaceutical company focused on developing transformative treatments to transform lives, starting with rare and serious liver diseases. Our purpose is simple, to empower people with the freedom to live healthier and more fulfilling lives, by unlocking new possibilities in life sciences and providing quality healthcare solutions.

Our lead drug candidate, saroglitazar, is a dual peroxisome proliferator-activated receptor (PPAR) alpha / gamma agonist. Saroglitazar is an investigational treatment which has received Fast Track designation, orphan drug designation and priority review designation from the US Food and Drug Administration (FDA) for the treatment of patients with primary biliary cholangitis (PBC). Primary Biliary Cholangitis is a rare, chronic autoimmune liver disease primarily affecting middle-aged women, characterized by the progressive destruction of the bile ducts that can lead to irreversible liver damage if left untreated.

As a wholly owned subsidiary of Zydus Lifesciences, our pipeline is fueled by 1,300 researchers who are working with cutting-edge technologies to discover new medicines for tomorrow.

The opportunity to empower people with the freedom to live healthier and more fulfilling lives is what makes a career with Zydus Therapeutics so rewarding. Our team is collaborative, innovative and adaptable. We are action-oriented and strive for excellence in all we do, all underpinned by respect, trust and integrity. We offer a wide variety of competitive benefits, services and support programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives

If you are passionate about helping bring potential life-changing discoveries to patients, then you share our mission.

Zydus Therapeutics is building the data and analytics engine for the anticipated US launch of saroglitazar in Primary Biliary Cholangitis, a new PPAR therapy for a serious rare hepatology indication. There are additional indications that Zydus Therapeutics is exploring for Saroglitazar through its clinical trial program. We are seeking a highly motivated and analytically driven Director, Data & Analytics to serve as the primary steward of the organization's commercial data ecosystem and analytics capabilities.

Reporting to the Executive Director, Data Analytics & Operations, this role will be responsible for owning & managing critical commercial data assets, driving leading edge analytics capabilities, owning the customer master, MDM, data governance council, and managing the supporting data and technology infrastructure that enables strategic decision-making across the organization.

The Director will lead the design, integration, governance, quality, and optimization of key commercial data sources including Komodo claims data, Quest laboratory data, Veeva Compass Patient Pathways, Veeva CRM, Veeva Network, Veeva Open Data, Definitive Healthcare, media data, omnichannel data, and other third-party data assets. In partnership with Commercial, Market Access, Medical Affairs, Marketing, Sales, Finance, and executive leadership, this individual will convert complex data into actionable business insights that support pre-launch and launch readiness activities, performance monitoring, patient journey analyses, market evaluation, omnichannel insights/action, and strategic planning for saroglitazar.

This role requires a hands‑on data and analytics leader who thrives in a lean, fast‑paced environment and can effectively bridge business objectives, advanced analytics, artificial intelligence, data management, and technology operations.

• Serve as the business owner and subject matter expert for all headquarters commercial data assets.
• Manage vendor relationships and data acquisition processes for Komodo claims data, Quest laboratory data, Veeva CRM, Network, Open Data, Veeva Compass Patient Pathways, Definitive Healthcare, Sales Force, Omnichannel, and other commercial data sources.
• Establish and maintain data governance processes and…